,trastuzumab deruxtecan
astrazeneca,roche,daiichi sankyo
['trastuzumab', 'destiny,breast,03', 'breast']
the #oncoalerttoptweet day 2 #asco22 presenting destiny breast03 at #asco22 trastuzumab deruxtecan trastuzumab emtansine in her2 unresectable and/or metastatic #breastcancer safety follow up best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??